VTRS

Latest SEC Filings & News for VTRS

3 most recent filings and news items mentioning VTRS. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/VTRS/news?limit=20"

Pull VTRS filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Viatris Q2 2026 results: Up 5% revenue, $550M returned to shareholders

Viatris reported Q2 2026 Total Revenues of $3.8B and Adjusted EBITDA of $1.2B. The company raised full-year 2026 guidance and returned $550M to shareholders.

View filing at SEC.gov →

Viatris Amends and Restates Term Loan Credit Agreement

Viatris Inc. entered into an amended and restated international term loan credit agreement dated July 1, 2026. This facility replaces the company's prior arrangement with Mizuho Bank, MUFG, and SMBC.

View filing at SEC.gov →

Viatris Issues €650M Senior Notes Due 2033 at 4.250%

Viatris Inc. completed an underwriting agreement to issue €650 million in senior notes due 2033 with a 4.250% coupon, guaranteed by Mylan Inc. and subsidiaries. The debt offering provides capital for the pharmaceutical company and is underwritten by major investment banks includi

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.